ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine.

Youyi Fong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.